NDC 68382-353

bupropion

Bupropion

bupropion is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Zydus Pharmaceuticals (usa) Inc.. The primary component is Bupropion Hydrochloride.

Product ID68382-353_3a335702-b823-4e62-abba-f7743c3c1b51
NDC68382-353
Product TypeHuman Prescription Drug
Proprietary Namebupropion
Generic NameBupropion
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2018-08-02
Marketing CategoryANDA / ANDA
Application NumberANDA201567
Labeler NameZydus Pharmaceuticals (USA) Inc.
Substance NameBUPROPION HYDROCHLORIDE
Active Ingredient Strength150 mg/1
Pharm ClassesAminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 68382-353-05

500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-353-05)
Marketing Start Date2018-08-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68382-353-05 [68382035305]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA201567
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-08-02

NDC 68382-353-10 [68382035310]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA201567
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-02

NDC 68382-353-06 [68382035306]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA201567
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-08-02

NDC 68382-353-16 [68382035316]

bupropion TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA201567
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-08-02

Drug Details

Active Ingredients

IngredientStrength
BUPROPION HYDROCHLORIDE150 mg/1

OpenFDA Data

SPL SET ID:8d937ca3-3351-40f1-8192-348ba0c68162
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 993557
  • 993541

    • Pharmacological Class

    • Aminoketone [EPC]
    • Dopamine Uptake Inhibitors [MoA]
    • Increased Dopamine Activity [PE]
    • Increased Norepinephrine Activity [PE]
    • Norepinephrine Uptake Inhibitors [MoA]

    Medicade Reported Pricing

    68382035305 BUPROPION HCL XL 150 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "bupropion" or generic name "Bupropion"

    NDCBrand NameGeneric Name
    0615-8262bupropionbupropion hydrochloride
    43547-288bupropionBupropion hydrochloride
    43547-289bupropionbupropion hydrochloride
    43547-290bupropionbupropion hydrochloride
    50090-3854bupropionbupropion hydrochloride
    50436-0289bupropionbupropion hydrochloride
    51655-357bupropionbupropion hydrochloride
    54868-5927Bupropionbupropion hydrochloride
    55700-644bupropionbupropion hydrochloride
    63187-521bupropionbupropion
    63629-8036bupropionbupropion hydrochloride
    65841-780bupropionbupropion
    65841-836bupropionbupropion
    67046-699BupropionBupropion
    68001-264bupropionbupropion
    68071-5214bupropionbupropion hydrochloride
    68382-353bupropionbupropion
    68382-354bupropionbupropion
    68788-7249bupropionbupropion
    68788-9255bupropionbupropion
    70518-1644bupropionbupropion
    71335-0801bupropionbupropion
    71335-0785bupropionbupropion
    70934-151bupropionbupropion
    68788-7283bupropionbupropion
    70518-2641bupropionbupropion
    71335-1622bupropionbupropion
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.